E. Boven
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Geriatrics and Gerontology top 10%
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 5
- Drug Transport and Resistance Mechanisms 5
- Colorectal Cancer Treatments and Studies 4
-
- Renal cell carcinoma treatment 3
- Co-authors
- Herbert M. Pinedo (9 shared papers)Giuseppe Giaccone (7 shared papers)H.E. Gall (2 shared papers)K. Mross (1 shared paper)Paul A. Maessen (1 shared paper)W J van der Vijgh (1 shared paper)G. Veerman (1 shared paper)Boudewijn J.M. Braakhuis (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (4 papers)International Journal of Cancer (3 papers)European Journal of Cancer (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
E. Boven
25 papers receiving 758 citations
Peers
Comparison fields: 5 of 81
- Oncology 405
- Geriatrics and Gerontology 40
- Family Practice 11
- Toxicology 20
- Pharmacology 47
Countries citing papers authored by E. Boven
This map shows the geographic impact of E. Boven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Boven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Boven more than expected).
Fields of papers citing papers by E. Boven
This network shows the impact of papers produced by E. Boven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Boven. The network helps show where E. Boven may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Boven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 165 | |
| 2 | Schedule-dependent antitumor effect of gemcitabine in in vivo model system. | 1995 | 128 |
| 3 | 2011 | 106 | |
| 4 | 1997 | 105 | |
| 5 | 1998 | 84 | |
| 6 | 1998 | 50 | |
| 7 | Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function. | 1999 | 40 |
| 8 | Palliative care for brain metastases of solid tumour types. | 1989 | 21 |
| 9 | 1995 | 20 | |
| 10 | 1997 | 15 | |
| 11 | Mitomycin C: interstitial pneumonitis and haemolytic-uraemic syndrome. | 1983 | 14 |
| 12 | 1994 | 10 | |
| 13 | 1995 | 9 | |
| 14 | 2009 | 7 | |
| 15 | [Adverse effects of the tyrosine-kinase inhibitor sunitinib, a new drug for the treatment of advanced renal-cell cancer]. | 2007 | 4 |
| 16 | [The hematopoietic growth factor GM-CSF in chemotherapy for advanced breast carcinoma]. | 1991 | 4 |
| 17 | 1997 | 3 | |
| 18 | 2007 | 2 | |
| 19 | 1999 | 2 | |
| 20 | 2009 | 2 |
About E. Boven
E. Boven is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pediatrics, Perinatology and Child Health and Hematology, having authored 25 papers that have together received 797 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Renal cell carcinoma treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Cancer Genomics and Diagnostics (2 papers), HIV/AIDS drug development and treatment (2 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Oncology (405 citations), Geriatrics and Gerontology (40 citations), Family Practice (11 citations), Toxicology (20 citations) and Pharmacology (47 citations). E. Boven has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Herbert M. Pinedo, Giuseppe Giaccone, H.E. Gall, K. Mross, Paul A. Maessen, W J van der Vijgh, G. Veerman, Boudewijn J.M. Braakhuis, Veronique W.T. Ruiz van Haperen and Godefridus J. Peters. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Cancer, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.